GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (NAS:GLPG) » Definitions » Price-to-Free-Cash-Flow

Galapagos NV (Galapagos NV) Price-to-Free-Cash-Flow : N/A (As of Apr. 26, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Galapagos NV Price-to-Free-Cash-Flow?

As of today (2024-04-26), Galapagos NV's share price is $28.63. Galapagos NV's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-6.95. Hence, Galapagos NV's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Galapagos NV's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 13 years, Galapagos NV's highest Price-to-Free-Cash-Flow Ratio was 17.86. The lowest was 1.97. And the median was 8.19.

GLPG's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 31.19
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Galapagos NV's Free Cash Flow per Share for the three months ended in Dec. 2023 was $-1.25. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-6.95.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 6.80% per year.

During the past 13 years, Galapagos NV's highest 3-Year average Free Cash Flow per Share Growth Rate was 246.20% per year. The lowest was -56.80% per year. And the median was 2.50% per year.


Galapagos NV Price-to-Free-Cash-Flow Historical Data

The historical data trend for Galapagos NV's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galapagos NV Price-to-Free-Cash-Flow Chart

Galapagos NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.54 - - - -

Galapagos NV Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Galapagos NV's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Galapagos NV's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galapagos NV's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galapagos NV's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Galapagos NV's Price-to-Free-Cash-Flow falls into.



Galapagos NV Price-to-Free-Cash-Flow Calculation

Galapagos NV's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=28.63/-6.951
=N/A

Galapagos NV's Share Price of today is $28.63.
Galapagos NV's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.95.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Galapagos NV  (NAS:GLPG) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Galapagos NV Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Galapagos NV's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Galapagos NV (Galapagos NV) Business Description

Address
Generaal De Wittelaan L11 A3, Mechelen, BEL, 2800
Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.